标题
Exploiting Epigenetic Alterations in Prostate Cancer
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 18, Issue 5, Pages 1017
出版商
MDPI AG
发表日期
2017-05-09
DOI
10.3390/ijms18051017
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Chemical probes targeting epigenetic proteins: Applications beyond oncology
- (2017) Suzanne Ackloo et al. Epigenetics
- Global Burden of Urologic Cancers, 1990–2013
- (2017) Geolani W. Dy et al. EUROPEAN UROLOGY
- Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains
- (2017) Léa Bouché et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer Efficacy
- (2017) Ying Huang et al. JOURNAL OF MEDICINAL CHEMISTRY
- The importance of DNA methylation in prostate cancer development
- (2017) Charles E. Massie et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer
- (2017) Di Zhao et al. NATURE
- An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED
- (2017) Wei Qi et al. Nature Chemical Biology
- The EED protein–protein interaction inhibitor A-395 inactivates the PRC2 complex
- (2017) Yupeng He et al. Nature Chemical Biology
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisition
- (2017) A Cannistraci et al. ONCOGENE
- MicroRNA-455-3p functions as a tumor suppressor by targeting eIF4E in prostate cancer
- (2017) Yongxiang Zhao et al. ONCOLOGY REPORTS
- Targeted protein degradation by PROTACs
- (2017) Taavi K. Neklesa et al. PHARMACOLOGY & THERAPEUTICS
- Recent scenario of microRNA as diagnostic and prognostic biomarkers of prostate cancer
- (2017) Kamla Kant Shukla et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor
- (2017) Yuning Liao et al. Cell Death & Disease
- Targeting Cancer Cells with BET Bromodomain Inhibitors
- (2017) Yali Xu et al. Cold Spring Harbor Perspectives in Medicine
- Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy
- (2017) Vito Cucchiara et al. Cancers
- Discovery and Molecular Basis of a Diverse Set of Polycomb Repressive Complex 2 Inhibitors Recognition by EED
- (2017) Ling Li et al. PLoS One
- Targeting cancer using KAT inhibitors to mimic lethal knockouts
- (2016) J. A. L. Brown et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Modulation of p300/CBP Acetylation of Nucleosomes by Bromodomain Ligand I-CBP112
- (2016) Beth E. Zucconi et al. BIOCHEMISTRY
- Immunotherapy for prostate cancer: False promises or true hope?
- (2016) Brian T. Rekoske et al. CANCER
- TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer
- (2016) Anna C. Groner et al. CANCER CELL
- Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness
- (2016) Vijayalakshmi Kari et al. EMBO REPORTS
- Phase I and II therapies targeting the androgen receptor for the treatment of castration resistant prostate cancer
- (2016) Athanasios Dellis et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Targeting epigenetic regulators for cancer therapy: modulation of bromodomain proteins, methyltransferases, demethylases, and microRNAs
- (2016) Kathy A. Gelato et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins
- (2016) Yasushi Taniguchi INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Reducible self-assembling cationic polypeptide-based micelles mediate co-delivery of doxorubicin and microRNA-34a for androgen-independent prostate cancer therapy
- (2016) Chong Yao et al. JOURNAL OF CONTROLLED RELEASE
- The roles of microRNAs in the progression of castration-resistant prostate cancer
- (2016) Satoko Kojima et al. JOURNAL OF HUMAN GENETICS
- The molecular underpinnings of prostate cancer: impacts on management and pathology practice
- (2016) Daniel Nava Rodrigues et al. JOURNAL OF PATHOLOGY
- Prostate cancer
- (2016) Gerhardt Attard et al. LANCET
- BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer
- (2016) I. A. Asangani et al. MOLECULAR CANCER RESEARCH
- Exploitation of Castration-Resistant Prostate Cancer Transcription Factor Dependencies by the Novel BET Inhibitor ABBV-075
- (2016) Emily J. Faivre et al. MOLECULAR CANCER RESEARCH
- KAT8 Regulates Androgen Signaling in Prostate Cancer Cells
- (2016) Ji-Young Kim et al. MOLECULAR ENDOCRINOLOGY
- Translational and clinical implications of the genetic landscape of prostate cancer
- (2016) Daniel E. Spratt et al. Nature Reviews Clinical Oncology
- Drug discovery in advanced prostate cancer: translating biology into therapy
- (2016) Timothy A. Yap et al. NATURE REVIEWS DRUG DISCOVERY
- Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
- (2016) Colin C. Pritchard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth
- (2016) X Deng et al. ONCOGENE
- PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer
- (2016) Kanak Raina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- P110β Inhibition Reduces Histone H3K4 Di-Methylation in Prostate Cancer
- (2016) Jun Pang et al. PROSTATE
- Novel and next-generation androgen receptor–directed therapies for prostate cancer: Beyond abiraterone and enzalutamide
- (2016) Richard M. Bambury et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Combination effect of therapies targeting the PI3K- and AR-signaling pathways in prostate cancer
- (2016) Shalini Singh Yadav et al. Oncotarget
- BET bromodomain-mediated interaction between ERG and BRD4 promotes prostate cancer cell invasion
- (2016) Alexandra M. Blee et al. Oncotarget
- Cellular androgen content influences enzalutamide agonism of F877L mutant androgen receptor
- (2016) Daniel J. Coleman et al. Oncotarget
- Histone demethylase lysine demethylase 5B in development and cancer
- (2016) Mengjiao Han et al. Oncotarget
- Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1
- (2016) Lien Spans et al. Oncotarget
- c-MYC drives histone demethylase PHF8 during neuroendocrine differentiation and in castration-resistant prostate cancer
- (2016) Peterson Kariuki Maina et al. Oncotarget
- Targeting BET bromodomain proteins in solid tumors
- (2016) Vaibhav Sahai et al. Oncotarget
- Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer
- (2016) Hannah Nip et al. Oncotarget
- Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer
- (2016) Narsis Attar et al. Cold Spring Harbor Perspectives in Medicine
- Epigenetic modulators as therapeutic targets in prostate cancer
- (2016) Inês Graça et al. Clinical Epigenetics
- ERG signaling in prostate cancer is driven through PRMT5-dependent methylation of the Androgen Receptor
- (2016) Zineb Mounir et al. eLife
- The HIF/PHF8/AR axis promotes prostate cancer progression
- (2016) D Tong et al. Oncogenesis
- The genomic evolution of human prostate cancer
- (2015) T Mitchell et al. BRITISH JOURNAL OF CANCER
- miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src
- (2015) X.-B. Shi et al. CANCER RESEARCH
- Coordinate Loss of MAP3K7 and CHD1 Promotes Aggressive Prostate Cancer
- (2015) L. U. Rodrigues et al. CANCER RESEARCH
- miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis
- (2015) Olivia Larne et al. CARCINOGENESIS
- Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters
- (2015) Nathaniel Melling et al. CARCINOGENESIS
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- The Molecular Taxonomy of Primary Prostate Cancer
- (2015) Adam Abeshouse et al. CELL
- The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond
- (2015) Nicole Stopa et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Phase I/II Study of Azacitidine, Docetaxel, and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Therapy
- (2015) Rakesh Singal et al. Clinical Genitourinary Cancer
- Implications of ubiquitin ligases in castration-resistant prostate cancer
- (2015) Jianfei Qi et al. CURRENT OPINION IN ONCOLOGY
- A phase II study of the HDAC inhibitor SB939 in patients with castration resistant prostate cancer: NCIC clinical trials group study IND195
- (2015) B. J. Eigl et al. INVESTIGATIONAL NEW DRUGS
- The Deubiquitinating Enzyme USP7 Regulates Androgen Receptor Activity by Modulating Its Binding to Chromatin
- (2015) Shu-Ting Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Androgen Receptor Coactivators in Regulation of Growth and Differentiation in Prostate Cancer
- (2015) Zoran Culig JOURNAL OF CELLULAR PHYSIOLOGY
- A SMYD3 Small-Molecule Inhibitor Impairing Cancer Cell Growth
- (2015) Alessia Peserico et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF
- (2015) James Bennett et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor
- (2015) Wylie S. Palmer et al. JOURNAL OF MEDICINAL CHEMISTRY
- The evolutionary history of lethal metastatic prostate cancer
- (2015) Gunes Gundem et al. NATURE
- Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies
- (2015) Siu Chiu Chan et al. NUCLEIC ACIDS RESEARCH
- HDAC inhibition impedes epithelial–mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer
- (2015) M Ruscetti et al. ONCOGENE
- Targeting BET bromodomains for cancer treatment
- (2015) Marie Jung et al. Epigenomics
- Microdissecting the role of microRNAs in the pathogenesis of prostate cancer
- (2015) Shiekh Gazalla Ayub et al. Cancer Genetics
- SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3
- (2015) Filipa Quintela Vieira et al. Oncotarget
- NCL1, a highly selective lysine-specific demethylase 1 inhibitor, suppresses prostate cancer without adverse effect
- (2015) Toshiki Etani et al. Oncotarget
- Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer.
- (2015) Anastasia Wyce et al. Oncotarget
- Demethylation of the miR-146a promoter by 5-Aza-2’-deoxycytidine correlates with delayed progression of castration-resistant prostate cancer
- (2014) Xiaolu Wang et al. BMC CANCER
- DNA methylation status is more reliable than gene expression at detecting cancer in prostate biopsy
- (2014) A Paziewska et al. BRITISH JOURNAL OF CANCER
- BET bromodomain inhibitors—A novel epigenetic approach in castration-resistant prostate cancer
- (2014) Sarah E Lochrin et al. CANCER BIOLOGY & THERAPY
- Androgen Receptor Is the Key Transcriptional Mediator of the Tumor Suppressor SPOP in Prostate Cancer
- (2014) C. Geng et al. CANCER RESEARCH
- The convergence of DNA damage checkpoint pathways and androgen receptor signaling in prostate cancer
- (2014) H. Q. Ta et al. ENDOCRINE-RELATED CANCER
- A Role for WDR5 in Integrating Threonine 11 Phosphorylation to Lysine 4 Methylation on Histone H3 during Androgen Signaling and in Prostate Cancer
- (2014) Ji-Young Kim et al. MOLECULAR CELL
- Coactivator MYST1 Regulates Nuclear Factor-κB and Androgen Receptor Functions During Proliferation of Prostate Cancer Cells
- (2014) Anbalagan Jaganathan et al. MOLECULAR ENDOCRINOLOGY
- Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
- (2014) Irfan A. Asangani et al. NATURE
- Three-tiered role of the pioneer factor GATA2 in promoting androgen-dependent gene expression in prostate cancer
- (2014) Dayong Wu et al. NUCLEIC ACIDS RESEARCH
- Novel Epigenetic Target Therapy for Prostate Cancer: A Preclinical Study
- (2014) Ilaria Naldi et al. PLoS One
- Global DNA hypomethylation in prostate cancer development and progression: a systematic review
- (2014) R Zelic et al. PROSTATE CANCER AND PROSTATIC DISEASES
- An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element
- (2014) M. R. Mansour et al. SCIENCE
- Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer
- (2014) J.-P. P. Theurillat et al. SCIENCE
- Connections between TET proteins and aberrant DNA modification in cancer
- (2014) Yun Huang et al. TRENDS IN GENETICS
- Epigenetic modifications in prostate cancer
- (2014) Marjolaine Ngollo et al. Epigenomics
- Intratumor DNA Methylation Heterogeneity Reflects Clonal Evolution in Aggressive Prostate Cancer
- (2014) David Brocks et al. Cell Reports
- A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer
- (2013) Dana E. Rathkopf et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Multifaceted role of EZH2 in breast and prostate tumorigenesis
- (2013) Gauri Deb et al. Epigenetics
- SMYD3 as an Oncogenic Driver in Prostate Cancer by Stimulation of Androgen Receptor Transcription
- (2013) Cheng Liu et al. JNCI-Journal of the National Cancer Institute
- The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer
- (2013) Vasundhra Kashyap et al. Molecular Oncology
- The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover
- (2013) Kelly Coffey et al. NUCLEIC ACIDS RESEARCH
- Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathways
- (2013) F Bruzzese et al. Cell Death & Disease
- EZH2, an epigenetic driver of prostate cancer
- (2013) Yeqing Angela Yang et al. Protein & Cell
- Transcription, DNA Damage and Beyond: The Roles of Histone Ubiquitination and Deubiquitination
- (2012) Hai-Ning Du CURRENT PROTEIN & PEPTIDE SCIENCE
- The enigmatic role of H2Bub1 in cancer
- (2012) Steven A. Johnsen FEBS LETTERS
- Regulation of the androgen receptor by post-translational modifications
- (2012) Kelly Coffey et al. JOURNAL OF ENDOCRINOLOGY
- Discovery and Characterization of NK13650s, Naturally Occurring p300-Selective Histone Acetyltransferase Inhibitors
- (2012) Shigehiro Tohyama et al. JOURNAL OF ORGANIC CHEMISTRY
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
- (2012) Christopher E Barbieri et al. NATURE GENETICS
- Increased levels of DNA methyltransferases are associated with the tumorigenic capacity of prostate cancer cells
- (2012) GIOVANNI LUCA GRAVINA et al. ONCOLOGY REPORTS
- Lestaurtinib Inhibits Histone Phosphorylation and Androgen-Dependent Gene Expression in Prostate Cancer Cells
- (2012) Jens Köhler et al. PLoS One
- Characterisation of a Tip60 Specific Inhibitor, NU9056, in Prostate Cancer
- (2012) Kelly Coffey et al. PLoS One
- Alterations of global histone H4K20 methylation during prostate carcinogenesis
- (2012) Turang E Behbahani et al. BMC Urology
- Histone Ubiquitination and Deubiquitination in Transcription, DNA Damage Response, and Cancer
- (2012) Jian Cao et al. Frontiers in Oncology
- Androgen Receptor Gene Expression in Prostate Cancer Is Directly Suppressed by the Androgen Receptor Through Recruitment of Lysine-Specific Demethylase 1
- (2011) Changmeng Cai et al. CANCER CELL
- Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells
- (2011) P. Ostling et al. CANCER RESEARCH
- Hormonal Therapy Promotes Hormone-Resistant Phenotype by Increasing DNMT Activity and Expression in Prostate Cancer Models
- (2011) Giovanni Luca Gravina et al. ENDOCRINOLOGY
- Selective Roles for cAMP Response Element-binding Protein Binding Protein and p300 Protein as Coregulators for Androgen-regulated Gene Expression in Advanced Prostate Cancer Cells
- (2011) Irina Ianculescu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Histone demethylation and steroid receptor function in cancer
- (2011) Antje Stratmann et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Histone H2B ubiquitin ligases RNF20 and RNF40 in androgen signaling and prostate cancer cell growth
- (2011) Tiina Jääskeläinen et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer
- (2011) Francesco Crea et al. Molecular Cancer
- Inhibition of the Acetyltransferases p300 and CBP Reveals a Targetable Function for p300 in the Survival and Invasion Pathways of Prostate Cancer Cell Lines
- (2011) F. R. Santer et al. MOLECULAR CANCER THERAPEUTICS
- USP10 deubiquitylates the histone variant H2A.Z and both are required for androgen receptor-mediated gene activation
- (2011) Ryan Draker et al. NUCLEIC ACIDS RESEARCH
- Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness
- (2011) S Huang et al. ONCOGENE
- Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion
- (2011) M Björkman et al. ONCOGENE
- EZH2and cancer stem cells: fact or fiction?
- (2011) Francesco Crea Epigenomics
- An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression
- (2010) Jindan Yu et al. CANCER CELL
- Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development
- (2010) T. Bianco-Miotto et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Androgen Receptor Signalling in Prostate Cancer: The Functional Consequences of Acetylation
- (2010) Derek N. Lavery et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- TAF1 Differentially Enhances Androgen Receptor Transcriptional Activity via Its N-Terminal Kinase and Ubiquitin-Activating and -Conjugating Domains
- (2010) Peyman Tavassoli et al. MOLECULAR ENDOCRINOLOGY
- 5-azacitidine restores and amplifies the bicalutamide response on preclinical models of androgen receptor expressing or deficient prostate tumors
- (2010) Giovanni Luca Gravina et al. PROSTATE
- Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC)
- (2009) L. R. Molife et al. ANNALS OF ONCOLOGY
- Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker
- (2009) P N Munster et al. BRITISH JOURNAL OF CANCER
- Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862)
- (2009) Deborah Bradley et al. CANCER
- Androgen-Induced Coactivator ANCCA Mediates Specific Androgen Receptor Signaling in Prostate Cancer
- (2009) J. X. Zou et al. CANCER RESEARCH
- Histone Deacetylases Are Required for Androgen Receptor Function in Hormone-Sensitive and Castrate-Resistant Prostate Cancer
- (2009) D. S. Welsbie et al. CANCER RESEARCH
- Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models
- (2009) Claudio Festuccia et al. ENDOCRINE-RELATED CANCER
- Tip60 promotes prostate cancer cell proliferation by translocation of androgen receptor into the nucleus
- (2009) Masaki Shiota et al. PROSTATE
- Global levels of histone modifications predict prostate cancer recurrence
- (2009) Jörg Ellinger et al. PROSTATE
- Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy
- (2008) W Weichert et al. BRITISH JOURNAL OF CANCER
- Defining the molecular action of HDAC inhibitors and synergism with androgen deprivation in ERG-positive prostate cancer
- (2008) Mari Björkman et al. INTERNATIONAL JOURNAL OF CANCER
- Phase II Trial of Docetaxel With Rapid Androgen Cycling for Progressive Noncastrate Prostate Cancer
- (2008) Dana Rathkopf et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic Androgen Receptor-Occupied Regions with Different Functions, Defined by Histone Acetylation, Coregulators and Transcriptional Capacity
- (2008) Li Jia et al. PLoS One
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Androgen receptor acetylation sites differentially regulate gene control
- (2007) Hortensia Faus et al. JOURNAL OF CELLULAR BIOCHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started